Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.9K
Overview
51.9K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

6.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pm6 from Triticum timopheevii encodes an NLR receptor that directly recognizes AvrPm6 to confer powdery mildew resistance in wheat.

Molecular plant·2025
Same author

Dosage effect genes modulate grain development in synthesized Triticum durum-Haynaldia villosa allohexaploid.

Journal of genetics and genomics = Yi chuan xue bao·2024
Same author

Shoot-to-root translocated GmNN1/FT2a triggers nodulation and regulates soybean nitrogen nutrition.

PLoS biology·2022
Same author

Functional assembly of root-associated microbial consortia improves nutrient efficiency and yield in soybean.

Journal of integrative plant biology·2021
Same author

Immunogenicity and protective efficacy of recombinant proteins consisting of multiple epitopes of foot-and-mouth disease virus fused with flagellin.

Applied microbiology and biotechnology·2019
Same author

A newly isolated Chinese virulent genotype GIIb porcine epidemic diarrhea virus strain: Biological characteristics, pathogenicity and immune protective effects as an inactivated vaccine candidate.

Virus research·2018

Related Experiment Video

Updated: Feb 12, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.3K

Flagellin as a vaccine adjuvant.

Baofeng Cui1,2, Xinsheng Liu1,2, Yuzhen Fang1,2

  • 1a State Key Laboratory of Veterinary Etiological Biology, OIE/National Foot and Mouth Disease Reference Laboratory, Key Laboratory of Animal Virology of Ministry of Agriculture , Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences , Lanzhou , China.

Expert Review of Vaccines
|March 28, 2018
PubMed
Summary

Bacterial flagellin acts as a potent adjuvant, enhancing immune responses for vaccine development. Its unique properties offer flexible strategies for creating effective flagellin-based vaccines against various diseases.

Keywords:
FlagellinNLRC4TLR5adjuvantinnate immunityvaccine

More Related Videos

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D
08:15

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D

Published on: December 9, 2022

2.3K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.4K

Related Experiment Videos

Last Updated: Feb 12, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.3K
In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D
08:15

In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D

Published on: December 9, 2022

2.3K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.4K

Area of Science:

  • Immunology
  • Vaccinology

Background:

  • Bacterial flagellin is a pathogen-associated molecular pattern (PAMP) that activates innate and adaptive immunity.
  • Flagellin's structural characteristics provide effective and flexible adjuvant activity for vaccine design.

Purpose of the Study:

  • To review recent advancements in flagellin's mechanism of action as a vaccine adjuvant.
  • To discuss the prospects of flagellin in developing novel vaccine strategies.

Main Methods:

  • Literature review of flagellin adjuvants using PubMed.
  • Analysis of flagellin structures, signaling pathways, natural immunity, and vaccine applications.
  • Evaluation of immunogenicity, safety, and efficacy data from clinical trials of flagellin-adjuvanted vaccines.

Main Results:

  • Flagellin is recognized for its ability to induce enhanced antigen-specific immune responses.
  • Flagellin-adjuvanted vaccines show promise for clinical progression.
  • Vaccine formulations incorporating PAMPs like flagellin maximize antigen potential.

Conclusions:

  • Flagellin serves as a valuable adjuvant, enhancing vaccine efficacy.
  • Combinations of flagellin with other adjuvants, such as TLR ligands, offer synergistic benefits for tailored vaccine development.